Pharming Group N.V. (PHAR) News Headlines

▮ More

Date

Headline

3/24/2023 8:46:39 PM Pharming Stock Reaps Significant Gains After Landmark FDA Approval

2/28/2023 3:45:54 AM Biotech Stocks Facing FDA Decision In March 2023

2/21/2023 1:04:09 AM Pharming Says First Patient Enrolled In Pediatric Clinical Trial Of Leniolisib In Rare Primary Immunodeficiency

12/15/2022 1:34:11 AM Pharming Reports Positive Interim Data From Study Of Leniolisib In Rare Primary Immunodeficiency

12/15/2022 1:05:43 AM Pharming Announces Positive Interim Analysis Data From Study Of Leniolisib In Rare Primary Immunodeficiency

12/7/2022 1:35:41 AM Pharming : Positive Data From Phase 3 Study Of Leniolisib In Rare Primary Immunodeficiency Published

12/7/2022 1:16:44 AM Pharming Announces Publication Of Positive Data From Phase 3 Study Of Leniolisib In Patients With APDS

10/11/2022 2:09:15 AM Pharming Seeks European Medicines Agency's Approval For Leniolisib In Treating APDS

10/11/2022 1:03:02 AM Pharming Group Submits Marketing Authorisation Application To European Medicines Agency For Leniolisib

9/28/2022 1:17:06 AM Pharming: FDA Accepts Leniolisib NDA For Priority Review To Treat APDS

9/28/2022 1:04:20 AM Pharming Group Says US FDA Accepts For Priority Review For Leniolisib NDA

2/2/2022 7:26:25 AM Pre-market Movers: MDJH, ELMS, EXC, PYPL, PHAR…

Older Articles